FDA Clearance Tracker · K212952
Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Phencyclidine in Hair
Last checked: Nov 20, 2026Latest source record: Apr 18, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Apr 18, 2022
Substantially Equivalent
Time to decision
214 days
Received Sep 16, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Unclassified
The decision
- FDA number
- K212952
- Device name
- Psychemedics Homogeneous Enzyme Immunoassay (HEIA) for Phencyclidine in Hair
- Applicant
- Psychemedics Corporation
- Applicant location
- Culver City, CA
- Received
- Sep 16, 2021
- Decided
- Apr 18, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Enzyme Immunoassay, Phencyclidine (LCM)
- Device class
- Unclassified
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LCM. The earliest in FDA's data is K790401, decided Jun 15, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K212952
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Psychemedics Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K210212 · Decided Dec 15, 2021 · 322 days after receipt
Device type: Gas Chromatography, Methamphetamine (LAF) · Laboratory Medicine & Pathology
K201326 · Decided Jul 27, 2021 · 434 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
K201228 · Decided Jun 25, 2021 · 414 days after receipt
Device type: Enzyme Immunoassay, Cocaine (JXO) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.